RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Laboratorio Reig Jofre Stock

Laboratorio Reig Jofre Equity 2024

Laboratorio Reig Jofre Equity

204.35 M EUR

Ticker

RJF.MC

ISIN

ES0165359029

WKN

A140EW

In 2024, Laboratorio Reig Jofre's equity was 204.35 M EUR, a 4.99% increase from the 194.63 M EUR equity in the previous year.

Laboratorio Reig Jofre Aktienanalyse

What does Laboratorio Reig Jofre do?

Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of drugs. The company was founded in 1929 by the Reig Jofre brothers in Barcelona, Spain. It has since become an international company with a wide portfolio of products and a high level of innovation and quality. The business model of Laboratorio Reig Jofre SA is based on implementing research and innovation in the field of pharmacy. The company has its own R&D department, which collaborates closely with major scientific organizations and universities in Spain to understand and apply the latest developments and innovations in the industry. Laboratorio Reig Jofre SA has three main divisions - human pharmaceuticals, veterinary medicine, and chemical products used in various industries such as cosmetics and food. The human pharmaceutical division includes a variety of products, including prescription drugs, over-the-counter products, and generics, with a focus on therapy areas such as oncology, antibiotics, gynecology, and central nervous system disorders. The veterinary medicine division provides a wide range of vaccines and medications for animal health. The third division of chemical products includes various products such as emulsifiers, preservatives, and natural dyes that can be used in different industries. Some of the most well-known products of Laboratorio Reig Jofre SA include the antibiotic Nitrofurantoin, the analgesic Algiasdin, the hormonal preparation Ovusitol, and the vaccine against Bluetongue in animals. The company has also carried out several successful acquisitions to expand its portfolio and strengthen its international presence. The acquisition of Derivados Quimicos SA (Derma SA) introduced Laboratorio Reig Jofre SA to the skincare sector and strengthened its presence in Latin America. The acquisition of Bioiberica SA introduced the company to the field of bioactive molecules and chondroprotectants. Laboratorio Reig Jofre SA is a company that places quality and innovation at the heart of its activities. The company has a strong corporate culture based on respect, transparency, integrity, and commitment. It has also shown a strong commitment to sustainability and social responsibility, with initiatives such as supporting projects to improve the health of women and children in Africa and implementing environmentally friendly practices in production. Overall, Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, capable of offering a wide range of products through research, innovation, and quality. With its diverse portfolio of products and its commitment to sustainability and social responsibility, the company is well-equipped to continue playing a leading role in the industry in the future. Laboratorio Reig Jofre ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Laboratorio Reig Jofre's Equity

Laboratorio Reig Jofre's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Laboratorio Reig Jofre's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Laboratorio Reig Jofre's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Laboratorio Reig Jofre's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Laboratorio Reig Jofre’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Laboratorio Reig Jofre stock

What is the equity of Laboratorio Reig Jofre this year?

Laboratorio Reig Jofre has equity of 204.35 M EUR this year.

What was the equity of Laboratorio Reig Jofre compared to the previous year?

The equity of Laboratorio Reig Jofre has increased/decreased by 4.99% increased compared to the previous year.

What impact does a high equity have on investors of Laboratorio Reig Jofre?

A high equity is advantageous for investors of Laboratorio Reig Jofre as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Laboratorio Reig Jofre?

A low equity can be a risk for investors of Laboratorio Reig Jofre, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Laboratorio Reig Jofre affect the company?

An increase in equity of Laboratorio Reig Jofre can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Laboratorio Reig Jofre affect the company?

A reduction in equity of Laboratorio Reig Jofre can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Laboratorio Reig Jofre?

Some factors that can affect the equity of Laboratorio Reig Jofre include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Laboratorio Reig Jofre so important for investors?

The equity of Laboratorio Reig Jofre is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Laboratorio Reig Jofre take to change the equity?

To change equity, Laboratorio Reig Jofre can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Laboratorio Reig Jofre pay?

Over the past 12 months, Laboratorio Reig Jofre paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 2.76 %. For the coming 12 months, Laboratorio Reig Jofre is expected to pay a dividend of 0.06 EUR.

What is the dividend yield of Laboratorio Reig Jofre?

The current dividend yield of Laboratorio Reig Jofre is 2.76 %.

When does Laboratorio Reig Jofre pay dividends?

Laboratorio Reig Jofre pays a quarterly dividend. This is distributed in the months of July, August, June, June.

How secure is the dividend of Laboratorio Reig Jofre?

Laboratorio Reig Jofre paid dividends every year for the past 10 years.

What is the dividend of Laboratorio Reig Jofre?

For the upcoming 12 months, dividends amounting to 0.06 EUR are expected. This corresponds to a dividend yield of 2.18 %.

In which sector is Laboratorio Reig Jofre located?

Laboratorio Reig Jofre is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratorio Reig Jofre kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratorio Reig Jofre from 6/21/2024 amounting to 0.04 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Laboratorio Reig Jofre pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of Laboratorio Reig Jofre in the year 2023?

In the year 2023, Laboratorio Reig Jofre distributed 0.996 EUR as dividends.

In which currency does Laboratorio Reig Jofre pay out the dividend?

The dividends of Laboratorio Reig Jofre are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratorio Reig Jofre

Our stock analysis for Laboratorio Reig Jofre Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorio Reig Jofre Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.